title: The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice.
abstract: BACKGROUND
  Islet transplantation has become a viable option for selected type 1 diabetic patients; however, a significant portion need to return to exogenous insulin. The predominant factors include impaired islet engraftment and early islet loss. Caspase inhibition is a potent way to improve islet engraftment, but all tested compounds so far have not been clinically relevant. IDN-6556 (PF3491390) has already been used clinically and can be delivered orally with high portal vein concentrations.
  
  
  METHODS
  Mice were given a marginal mass islet graft of either mouse or human islets and treated with either IDN-6556 (10 or 20 mg/kg ip bid) or vehicle and followed for diabetes reversal. At 1 month post-transplant, mice were subjected to a glucose tolerance test and an assessment of graft mass. In separate experiments, human islets were cultured with IDN-6556 or vehicle to assess for islet survival and viability.
  
  
  RESULTS
  In both syngeneic mouse islets and human islets transplanted into immunodeficient mice, IDN-6556 (20 mg/kg) given for 7 days post-transplant led to a significantly enhanced rate of diabetes reversal as compared to vehicle. In addition, mice receiving caspase inhibitor displayed improved glucose tolerance and graft survival at the 1-month point. We also found protective effects in vitro for islet viability and marked reduction in apoptosis in vivo.
  
  
  CONCLUSIONS
  Taken together, these results demonstrate the effectiveness of caspase inhibition with IDN-6556 on islet transplantation and in particular islet engraftment and survival.
authors: Department of Surgery, University of Alberta, Edmonton, Canada. mmccall@ualberta.ca
authors: Michael
authors: M
authors: McCall
authors: Christian
authors: C
authors: Toso
authors: Juliet
authors: J
authors: Emamaullee
authors: Rena
authors: R
authors: Pawlick
authors: Ryan
authors: R
authors: Edgar
authors: Joy
authors: J
authors: Davis
authors: Allison
authors: A
authors: Maciver
authors: Tatsuya
authors: T
authors: Kin
authors: Robert
authors: R
authors: Arch
authors: A M James
authors: AM
authors: Shapiro